Thrombosomes for Expanded Access Use
NCT04619108 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2024-03-21
Summary
Expanded use of Thrombosomes where a clinical trial with Thrombosomes is not an option, Cellphire may elect to provide the Sponsor/Investigator (S/I) expanded access to its investigational product, Thrombosomes.
Conditions
Interventions
- BIOLOGICAL
-
Thrombosomes®
Sponsors & Collaborators
-
Cellphire Therapeutics, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap
NCT01575756 ·Status: COMPLETED ·Phase: PHASE2
-
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
NCT04647227 ·Status: RECRUITING ·Phase: PHASE4
-
Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery
NCT01561391 ·Status: COMPLETED ·Phase: PHASE4
-
Ascending Dose Study of Genome Editing by Zinc Finger Nuclease Therapeutic SB-FIX in Subjects With Severe Hemophilia B
NCT02695160 ·Status: TERMINATED ·Phase: PHASE1
-
Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis
NCT00491608 ·Status: COMPLETED ·Phase: PHASE3
-
Gene Therapy Study in Severe Haemophilia A Patients (270-201)
NCT02576795 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A
NCT01619046 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Recombinant Factor VIIa Fusion Protein (rVIIa-FP, CSL689) for On-demand Treatment of Bleeding Episodes in Patients With Hemophilia A or B With Inhibitors
NCT02484638 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A
NCT01568580 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A
NCT00989196 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
NCT06379789 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery.
NCT02250560 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia B
NCT05164471 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures
NCT01913405 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inhibitors
NCT02020369 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Fibryga, a Fibrinogen Concentrate in Real World: Retrospective Collection of Clinical Data
NCT04106895 ·Status: COMPLETED
-
Hematopoietic Stem Cell Transplantation Gene Therapy for Treatment of Severe Hemophilia A
NCT04418414 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia
NCT00108758 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A
NCT01486927 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia A
NCT01454739 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Study of ADVATE Reconstituted in 2 mL Sterile Water for Injection
NCT00952822 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor VIIa With Albumin (rVIIa-FP) in Healthy Male Volunteers
NCT01542619 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM
NCT05695391 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of an Absorbable Surgical Hemostatic Agent: Thrombi-Gel® Versus Gelfoam-Thrombin
NCT00652314 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics of Single Bolus Dose of NovoSeven® in Paediatric and Adult Patients With Haemophilia A or B in a Non- Bleeding State
NCT01562587 ·Status: COMPLETED ·Phase: PHASE1